Rephonic
Artwork for Tech and Drugs

Tech and Drugs - Podcast

Thibault Geoui
Artificial Intelligence
Drug Discovery
AI In Pharma
Ginkgo Bioworks
Karger Publishers
Pharma
AI In Drug Discovery
Data Analytics
Peer Review
Scientific Publishing
Converge Bio
Generative AI
Antibody Design
Neuroscience
Alzheimer's Disease
High-Throughput Biology
Bio-Foundation Models
Molecular Design (MDL)
Molecular Dynamics
Virtual Cell

Welcome to Tech and Drugs, the podcast exploring how data and AI are revolutionizing Pharma and Biotech. Each episode features candid conversations with industry experts tackling real-world challenges, sharing success stories, and lessons learned. Explore how digital transformation accelerates breakthroughs and bridges the gap between tech and science. 🔍 What You’ll Discover: • How AI is driving ... more

PublishesMonthlyEpisodes19Founded2 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Tech and Drugs

Latest Episodes

In this Tech & Drugs episode, I sit down with Mathieu Bourdenx, Group Leader at the UK Dementia Research Institute / UCL, to explore how AI agents and AI co-scientists are beginning to change neuroscience research.We discuss brain aging, Alzheimer’s ... more

In this Tech & Drugs episode, I sit down with Thomas Steger-Hartmann, former investigational toxicology lead at Bayer and industry lead of the VICTOR Consortium, to explore the future of drug safety.We discuss how toxicology is moving from descriptiv... more

In this Tech & Drugs episode, I sit down with Patrick Ansems, globally responsible for life sciences strategy at Siemens across pharma and medical devices, to explore how AI, data, automation, and platforms are reshaping drug development.Recorded liv... more

In this Tech & Drugs episode, I sit down with Laura Matz, Chief Science and Technology Officer at Merck KGaA Darmstadt, Germany, to explore how AI, data, automation, and digital technologies are reshaping science at scale.Laura brings a rare perspect... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Mathieu Bourdenx
Lead researcher focusing on brain aging at UK Dementia Research Institute, University College London
UK Dementia Research Institute, UCL
Episode: When AI Generates the Scientific Hypothesis | Mathieu Bourdenx, UK Dementia Research Institute @UCL
Thomas Steger-Hartmann
Leader in investigational toxicology at Bayer; industry lead of the VICTOR Consortium
Bayer
Episode: Can AI Reduce Animal Testing in Toxicology? With Dr. Thomas Steger-Hartmann
Patrick Ansems
Global head of life sciences strategy at Siemens, spanning pharma and medical devices
Siemens
Episode: AI in Pharma: From Molecule to Market with Siemens' Patrick Ansems
Laura Matz
Chief Science and Technology Officer at Merck KGaA
Merck KGaA, Darmstadt, Germany
Episode: AI, Autonomous Labs, and the Future of Science - Laura Matz (Merck KGaA, Darmstadt, Germany)
Walid Kamoun
Head of Oncology, R&D at Servier
Servier
Episode: Servier's Walid Kamoun on AI and the Future of Oncology R&D
Dov Gertz
CEO and co-founder of Converge Bio
Converge Bio
Episode: From Code to Cells: Dov Gertz of Converge Bio on Generative AI and the Future of Drug Discovery
Tim Hoctor
Industry veteran in life sciences data and pharma software
MDL/Elsevier (former)
Episode: From Tennis Courts to Molecular Design: Tim Hoctor on Data, Discovery, and the Future of Pharma
Mitja-Alexander Linss
Head of Marketing at Karger Publishers
Karger Publishers
Episode: Inside Scientific Publishing, AI, and the Future of Medical Knowledge with Mitja-Alexander Linss
Rick Schneider
Co-founder and CEO of Helical
Helical
Episode: Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery

Host

Thibaut
Host of the show

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

When AI Generates the Scientific Hypothesis | Mathieu Bourdenx, UK Dementia Research Institute @UCL
Q: What key trends do you see in biotech and neuroscience as AI becomes more integrated into research workflows?
The trend is toward building digital brains for researchers and labs to capture and traverse thought processes, moving from research execution to research operation, enabling scalable data integration, meta-analysis, and continuous knowledge updates that could transform publishing and discovery cycles.
When AI Generates the Scientific Hypothesis | Mathieu Bourdenx, UK Dementia Research Institute @UCL
Q: As we move toward AI-enabled tools, how do you address trust and verification in the results these agents produce?
Trust is addressed through three layers: code review of the agents, rigorous literature verification with traceable citations, and ensemble verification where multiple agents check claims to filter out spurious results, coupled with domain expertise to interpret outputs.
When AI Generates the Scientific Hypothesis | Mathieu Bourdenx, UK Dementia Research Institute @UCL
Q: What was your reaction when you used that for the first time and saw the autonomous loop actually generate a credible hypothesis?
The initial runs produced surprising yet credible findings; the autonomous loop appeared to generate hypotheses and validate them through data and literature, which felt mind-blowing and transformative for how research could be conducted.
When AI Generates the Scientific Hypothesis | Mathieu Bourdenx, UK Dementia Research Institute @UCL
Q: So Kosmos is how to call it like an AI coscientist. Can you explain in your own word what's Kosmos and how you got involved with the team behind that?
Kosmos is an environment with multiple small autonomous agents that together perform the full scientific process: formulate hypotheses, search literature, analyze data, and iteratively refine ideas through a shared world model, enabling faster and more iterative discoveries.
Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery
Q: What one piece of advice would you give to a young entrepreneur starting a disruptive startup today?
Distinguish yourself by being genuinely different in a way that adds real value; adopt a model-agnostic stance and focus on solving real customer needs rather than building a pipeline for your own company.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Tech and Drugs

What is Tech and Drugs about and what kind of topics does it cover?

Conversations center on the intersection of data, AI, and life sciences, with frequent focus on how AI-enabled drug discovery, computational biology, and data-driven workflows are accelerating pharma and biotech. Episodes showcase senior executives and researchers discussing practical use cases—from AI in synthetic chemistry and protein design to data platforms, high-throughput biology, and publishing tech—to illuminate the path from research to patient impact. Noteworthy angles include organizational change, regulatory considerations, open-source and open-data movements, and the evolving role of big tech, startups, and partnerships in TechBio. The show tends to feature founders, CROs, publishers, and platform leaders who offer pragmatic le... more

Where can I find podcast stats for Tech and Drugs?

Rephonic provides a wide range of podcast stats for Tech and Drugs. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Tech and Drugs and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Tech and Drugs get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Tech and Drugs, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Tech and Drugs?

Rephonic provides comprehensive predictive audience data for Tech and Drugs, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Tech and Drugs have?

To see how many followers or subscribers Tech and Drugs has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Tech and Drugs?

These podcasts share a similar audience with Tech and Drugs:

1. The Top Line
2. Dwarkesh Podcast
3. All-In with Chamath, Jason, Sacks & Friedberg
4. The AI Daily Brief: Artificial Intelligence News and Analysis

How many episodes of Tech and Drugs are there?

Tech and Drugs launched 2 years ago and published 19 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Tech and Drugs?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Tech and Drugs?

Rephonic pulls ratings and reviews for Tech and Drugs from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Tech and Drugs?

Rephonic provides full transcripts for episodes of Tech and Drugs. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Tech and Drugs?

Recent guests on Tech and Drugs include:

1. Mathieu Bourdenx
2. Thomas Steger-Hartmann
3. Patrick Ansems
4. Laura Matz
5. Walid Kamoun
6. Dov Gertz
7. Tim Hoctor
8. Mitja-Alexander Linss

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days